1 |
CAPLAN A I. Mesenchymal stem cells[J]. J. Orthop. Res., 1991, 9(5): 641-650.
|
2 |
GAO F, CHIU S, MOTAN D, et al.. Mesenchymal stem cells and immunomodulation: current status and future prospects[J/OL]. Cell Death Dis., 2016, 7(1): e2062[2021-09-27] . .
|
3 |
ANNA A, BARBARA L, MIROSLAW J, et al.. Concise review: mesenchymal stem cells: from roots to boost[J]. Stem cells, 2019, 34(3): 76-78.
|
4 |
SUGRUE T, BROWN J A L, LOWNDES N F, et al.. Multiple Facets of the DNA damage response contribute to the radioresistance of mouse mesenchymal stromal cell lines[J]. Stem Cells, 2013, 31(1): 77-83.
|
5 |
GRONTHOS S, MANKANI M, BRAHIM J, et al.. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo[J]. Proc. Natl. Acad. Sci. USA, 2000, 97(25): 13625-13630.
|
6 |
JACKSON W M, NESTI L J, TUAN R S. Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells[J]. Expert Opin. Biol. Ther., 2010, 10(4): 505-517.
|
7 |
BARI C D, DELL' ACCIO F, TYLZANOWSKI P, et al.. Multipotent mesenchymal stem cells from adult human synovial membrane[J]. J. Rheumatol., 2001, 44(8): 1928-1942.
|
8 |
ZUK P A, ZHU M, MIZUNO H, et al.. Multilineage cells from human adipose tissue: implications for cell-based therapies.[J]. Tissue Eng. Part A, 2001, 7(2): 211-228.
|
9 |
DOMINICI M, LE BLANC K, MUELLER I, et al.. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement [J]. Cytotherapy, 2006, 8(4): 315-317.
|
10 |
SAMNATHA F H, FRANKA LUK, JESUS M,et al.. Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells[J]. Stem Cells, 2018, 36(S6): 602-615.
|
11 |
F D CGON ALVES, LUK F, KOREVAAR S S, et al.. Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes[J/OL]. Sci. Rep., 2017, 7(1):12100[2021-09-27] ..
|
12 |
JIN-HEE K, JO C H, HANG-RAE K, et al.. Comparison of immunological characteristics of mesenchymal stem cells from the periodontal ligament, umbilical cord, and adipose tissue[J]. Stem Cells Int., 2018, 2018: 1-12.
|
13 |
PAPACCIO F, PAINO F, REGAD T, et al.. Concise review: cancer cells, cancer stem cells, and mesenchymal stem cells: influence in cancer development[J]. Stem Cells Transl. Med., 2017, 6(12): 2115-2125.
|
14 |
KARNOUB A E, DASH A B, VO A P, et al.. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis[J]. Nature, 2007, 449(7162): 557-563.
|
15 |
KUCEROVA L, MATUSKOVA M, HLUBINOVA K, et al.. Tumor cell behaviour modulation by mesenchymal stromal cells[J/OL]. Mol. Cancer, 2010, 9(1): 129[2021-09-27] ..
|
16 |
PRANTL L, MUEHLBERG F, NAVONE N M, et al.. Adipose tissue derived stem cells promote prostate tumor growth[J]. Prostate, 2010, 70(15):70(15):1709-1715.
|
17 |
MATUS S, MARINI F C, DEMBINSKI J L, et al.. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents[J]. J. Natl. Cancer Inst., 2004, 96(21): 1593-1603.
|
18 |
MCGUIRE J J, FRIELING J S, LO C H, et al.. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer[J/OL]. Nat. Commun., 2021, 12(1):723[2021-09-27] ..
|
19 |
YOU Q, YAO Y, ZHANG Y, et al.. Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo[J]. Mol. Med. Rep., 2015, 12(4): 4859-4866.
|
20 |
JIA Y, DING X, ZHOU L, et al.. Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1[J]. Oncogene, 2021, 40, 246-261.
|
21 |
SUN X Y, NONG J, QIN K, et al.. MSC TRAIL-mediated HepG2 cell death in direct and indirect co-cultures[J]. Anticancer Res., 2011, 31(11): 3705-3712.
|
22 |
AH C S, SUNG-KYUN H, KYU-CHANG W, et al.. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma[J]. Neuro. Oncol., 13(1): 61-69.
|
23 |
JING W, CHEN Y, LU L, et al.. Human umbilical cord blood-derived mesenchymal stem cells producing IL15 eradicate established pancreatic tumor in syngeneic mice[J]. Mol. Cancer Ther., 2014, 13(8): 2127.
|
24 |
CÉLIA M F G. The dual role of mesenchymal stem cells in tumor progression[J]. Stem Cell Res. Ther., 2013, 4(2): 1-2.
|
25 |
MUSTOE T A, O'SHAUGHNESSY K, KLOETERS O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis[J]. Plast. Reconstr. Surg., 2006, 117(7s): 35-41.
|
26 |
MAZINI L, ROCHETTE L, ADMOU B, et al.. Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing[J]. Int. J. Mol. Sci., 2020, 21(4): 1-19.
|
27 |
SHIN S C, SEO Y, PARK H Y, et al.. Regenerative potential of tonsil mesenchymal stem cells on surgical cutaneous defect[J/OL]. Cell Death Dis., 2018, 9(2): 183[2021-09-27] ..
|
28 |
SHANG Q, CHU Y, LI Y, et al.. Adipose-derived mesenchymal stromal cells promote corneal wound healing by accelerating the clearance of neutrophils in cornea[J/OL]. Cell Death Dis., 2020, 11(8): 707[2021-09-27] ..
|
29 |
HANSON S E, KLEINBECK K R, CANTU D, et al.. Local delivery of allogeneic bone marrow and adipose tissue-derived mesenchymal stromal cells for cutaneous wound healing in a porcine model[J/OL]. J. Tissue Eng. Regen. Med., 2016, 10(2):E90-E100[2021-09-27] . .
|
30 |
SELLHEYER K, KRAHL D. Cutaneous mesenchymal stem cells. Current status of research and potential clinical applications[J]. Der. Hautarzt., 2010, 61(5): 429-434.
|
31 |
SOPHIE P F, HOLGER S, AMY L, et al.. A role for pericytes as microenvironmental regulators of human skin tissue regeneration[J]. J. Clin. Invest., 2009, 119(9): 2795-806
|
32 |
FRIEDMAN S L, SHEPPARD D, DUFFIELD J S, et al.. Therapy for fibrotic diseases: nearing the starting line[J/OL]. Sci. Transl. Med., 2013, 5(167):167sr1[2021-09-27] ..
|
33 |
XU T, ZHANG Y, CHANG P, et al.. Mesenchymal stem cell-based therapy for radiation-induced lung injury[J]. Stem Cell Res. Ther., 2018, 9(1): 18.
|
34 |
MOHAMADNEJAD M, ALIMOGHADDAM K, MOHYEDDINBONAB M, et al.. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis[J]. Arch. Iran. Med., 2007,10(4):459-466.
|
35 |
KHARAZIHA P, HELLSTRM P M, NOORINAYER B, et al.. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial[J]. Eur. J. Gastroenterol. Hepatol., 2009, 21(10): 1199-1205.
|
36 |
SELIM R E, AHMED H H, ABD-ALLAH S H, et al.. Mesenchymal stem cells: a promising therapeutic tool for acute kidney injury[J]. Appl. Biochem. Biotechnol., 2019, 189(1):284-304.
|
37 |
KISHORE R, VERMA S K, MACKIE A R, et al.. Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts[J/OL]. PLoS ONE, 2013, 8(4): e60161[2021-09-27] ..
|
38 |
LIU L, JIN X, HU C F, et al.. Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia/reperfusion injury by inducing cardiomyocyte autophagy via AMPK and Akt pathways[J]. Cell Physiol. Biochem., 2017, 43(1): 52-68.
|
39 |
GONZALEZ-KING H, GARCÍA NA, ONTORIA-OVIEDO I, et al.. Hypoxia inducible factor-1alpha potentiates jagged 1- mediated angiogenesis by mesenchymal stem cell-derived exosomes[J]. Stem Cells, 2017, 35(7): 1747-1759.
|
40 |
MITEVA K, PAPPRITZ K, EL-SHAFEEY M, et al.. Mesenchymal stromal cells modulate monocytes trafficking in coxsackievirus B3-induced myocarditis[J]. Stem Cells Transl., 2017, 6(4): 1249-1261.
|
41 |
GUO Y, YU Y, HU S, et al.. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases[J/OL]. Cell Death Dis., 2020, 11(5): 349[2021-09-27]. .
|
42 |
FILLMORE N, HUQI A, JASWAL J S, et al.. Effect of fatty acids on human bone marrow mesenchymal stem cell energy metabolism and survival[J/OL]. PLoS ONE, 2015, 13:10(3):e01202579[2021-09-27]. .
|